Your browser doesn't support javascript.
loading
Molecular Mechanisms of Desensitization Underlying the Differential Effects of Formyl Peptide Receptor 2 Agonists on Cardiac Structure-Function Post Myocardial Infarction.
Lupisella, John; St-Onge, Stéphane; Carrier, Marilyn; Cook, Erica M; Wang, Tao; Sum, Chi; Fernando, Gayani; Apgar, Kendra; Zhang, Rongan; Carson, Nancy; Snyder, Bradley J; Ryan, Carol S; Ma, Xiuying; Dierks, Elizabeth A; Little, Sean; Kick, Ellen K; Wurtz, Nicholas R; Bouvier, Michel; Héroux, Madeleine; Garcia, Ricardo A.
Afiliación
  • Lupisella J; Department of Cardiovascular and Fibrosis Drug Discovery, Bristol Myers Squibb, P.O. Box 4000 Princeton, New Jersey08543-4000, United States.
  • St-Onge S; Institute for Research in Immunology and Cancer, Université de Montréal, QuebecH3T 1J4, Canada.
  • Carrier M; Institute for Research in Immunology and Cancer, Université de Montréal, QuebecH3T 1J4, Canada.
  • Cook EM; Department of Lead Discovery and Optimization, Bristol Myers Squibb, P.O. Box 4000 Princeton, New Jersey08543-4000, United States.
  • Wang T; Department of Lead Discovery and Optimization, Bristol Myers Squibb, P.O. Box 4000 Princeton, New Jersey08543-4000, United States.
  • Sum C; Department of Lead Discovery and Optimization, Bristol Myers Squibb, P.O. Box 4000 Princeton, New Jersey08543-4000, United States.
  • Fernando G; Department of Cardiovascular and Fibrosis Drug Discovery, Bristol Myers Squibb, P.O. Box 4000 Princeton, New Jersey08543-4000, United States.
  • Apgar K; Department of Cardiovascular and Fibrosis Drug Discovery, Bristol Myers Squibb, P.O. Box 4000 Princeton, New Jersey08543-4000, United States.
  • Zhang R; Department of Cardiovascular and Fibrosis Drug Discovery, Bristol Myers Squibb, P.O. Box 4000 Princeton, New Jersey08543-4000, United States.
  • Carson N; Department of Cardiovascular and Fibrosis Drug Discovery, Bristol Myers Squibb, P.O. Box 4000 Princeton, New Jersey08543-4000, United States.
  • Snyder BJ; Department of Cardiovascular and Fibrosis Drug Discovery, Bristol Myers Squibb, P.O. Box 4000 Princeton, New Jersey08543-4000, United States.
  • Ryan CS; Department of Cardiovascular and Fibrosis Drug Discovery, Bristol Myers Squibb, P.O. Box 4000 Princeton, New Jersey08543-4000, United States.
  • Ma X; Department of Cardiovascular and Fibrosis Drug Discovery, Bristol Myers Squibb, P.O. Box 4000 Princeton, New Jersey08543-4000, United States.
  • Dierks EA; Department of Drug Metabolism and Pharmacokinetics, Bristol Myers Squibb, P.O. Box 4000 Princeton, New Jersey08543-4000, United States.
  • Little S; Department of Cardiovascular and Fibrosis Drug Discovery, Bristol Myers Squibb, P.O. Box 4000 Princeton, New Jersey08543-4000, United States.
  • Kick EK; Department of Cardiovascular Discovery Chemistry, Bristol Myers Squibb, P.O. Box 4000 Princeton, New Jersey08543-4000, United States.
  • Wurtz NR; Department of Cardiovascular Discovery Chemistry, Bristol Myers Squibb, P.O. Box 4000 Princeton, New Jersey08543-4000, United States.
  • Bouvier M; Institute for Research in Immunology and Cancer, Université de Montréal, QuebecH3T 1J4, Canada.
  • Héroux M; Institute for Research in Immunology and Cancer, Université de Montréal, QuebecH3T 1J4, Canada.
  • Garcia RA; Department of Cardiovascular and Fibrosis Drug Discovery, Bristol Myers Squibb, P.O. Box 4000 Princeton, New Jersey08543-4000, United States.
ACS Pharmacol Transl Sci ; 5(10): 892-906, 2022 Oct 14.
Article en En | MEDLINE | ID: mdl-36268126

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: ACS Pharmacol Transl Sci Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: ACS Pharmacol Transl Sci Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Estados Unidos